Holen Sie sich die Stockscreener-App
47.87
0.04%
0.02
Handel nachbörslich:
47.88
0.01
+0.02%
Schlusskurs vom Vortag:
$47.85
Offen:
$47.87
24-Stunden-Volumen:
736.93K
Relative Volume:
0.93
Marktkapitalisierung:
$1.23B
Einnahmen:
-
Nettoeinkommen (Verlust:
$11.77M
KGV:
82.75
EPS:
0.5785
Netto-Cashflow:
$-19.23M
1W Leistung:
-0.06%
1M Leistung:
+0.57%
6M Leistung:
+295.62%
1J Leistung:
+74.20%
1-Tages-Spanne:
$47.85
$47.90
1-Wochen-Bereich:
$47.83
$47.92
52-Wochen-Spanne:
$11.56
$48.27
Tourmaline Bio Inc Stock (TRML) Company Profile
Firmenname
Tourmaline Bio Inc
Sektor
Branche
Telefon
646-481-9832
Adresse
27 WEST 24TH STREET, NEW YORK
Vergleichen Sie TRML mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
47.87 | 1.23B | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-06 | Eingeleitet | Wedbush | Outperform |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-11-11 | Bestätigt | H.C. Wainwright | Buy |
| 2023-12-15 | Eingeleitet | Jefferies | Buy |
| 2023-12-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-17 | Eingeleitet | Truist | Buy |
| 2023-10-31 | Eingeleitet | Guggenheim | Buy |
| 2023-10-25 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
How to forecast Tourmaline Bio Inc. trends using time series2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Tourmaline Bio (NASDAQ:TRML) - MarketBeat
How to read the order book for Tourmaline Bio Inc.Recession Risk & AI Optimized Trade Strategies - newser.com
Can a trend reversal in Tourmaline Bio Inc. lead to recoveryTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate Merger – TRML, PNFP, MRCC, and UNP - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Inside INdiana Business - FinancialContent
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc.TRML | FinancialContent - FinancialContent
Custom strategy builders for tracking Tourmaline Bio Inc.Fed Meeting & Daily Growth Stock Tips - newser.com
Will Tourmaline Bio Inc. stock outperform growth indexesJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Using flow based indicators on Tourmaline Bio Inc.2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Sees Large Decline in Short Interest - MarketBeat
Is Tourmaline Bio Inc. forming a bottoming baseWatch List & Fast Entry Momentum Alerts - newser.com
What MACD signals say about Tourmaline Bio Inc.Portfolio Performance Report & Accurate Technical Buy Alerts - newser.com
Can Tourmaline Bio Inc. recover in the next quarter2025 Big Picture & Technical Entry and Exit Alerts - newser.com
Technical analysis overview for Tourmaline Bio Inc. stockJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com
Is Tourmaline Bio Inc. stock a buy in volatile marketsJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Hold" by Analysts - MarketBeat
Identifying reversal signals in Tourmaline Bio Inc.Earnings Risk Summary & Safe Entry Zone Tips - newser.com
Tourmaline Bio (TRML) Price Target Decreased by 14.70% to 48.90 - MSN
Novartis commences tender offer to buy Tourmaline Bio - Medical Dialogues
Wild Moves In Stocks From Crypto Plans, Deal News, And A Name Drop - Finimize
Tourmaline Bio stock hits 52-week high at 47.8 USD By Investing.com - Investing.com Nigeria
Tourmaline Bio stock hits 52-week high at 47.8 USD - Investing.com
Tourmaline Bio (NASDAQ:TRML) Sets New 52-Week HighHere's Why - MarketBeat
Tourmaline Bio Inc Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Novartis announces commencement of tender offer to acquire Tourmaline Bio29.09.25News - Ariva
Novartis launches tender offer for Tourmaline Bio - MarketScreener
Is Tourmaline Bio Inc a good long term investmentBull Market Opportunities & Outstanding Investment Returns - earlytimes.in
Published on: 2025-09-25 13:32:41 - newser.com
Tourmaline Bio (NASDAQ:TRML) Sets New 1-Year HighStill a Buy? - MarketBeat
Upcoming Events - FinancialContent
Goldman Sachs Group Inc. Lowers Position in Tourmaline Bio, Inc. $TRML - MarketBeat
Wesbanco Bank Inc. Takes Position in Tourmaline Bio, Inc. $TRML - MarketBeat
Tourmaline Bio, Inc. Hits New 52-Week High of $47.76 - Markets Mojo
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):